CTTI Article Uncovers Why Principal Investigators Conduct Multiple FDA-Regulated Drug Trials

Building on a previous study on the reasons why principal investigators conduct only one FDA-regulated drug trial (“one-and-done” investigators), a new CTTI article published in Contemporary Clinical Trials Communications explores the converse: barriers and critical factors that contribute to “active” investigators’ success while conducting multiple trials.

Through in-depth interviews with 23 experienced investigators, CTTI found that “active” investigators cited infrastructure, staff support, advance planning, and personal qualities as critical factors in successfully conducting multiple trials. They also shared many of the same barriers and frustrations that “one-and-done” investigators faced—including trial finances and patient recruitment—however, “active” investigators had developed strategies to overcome these barriers. Of particular importance, the amount and type of support to which investigators have access may represent a crucial difference between “active” and “one-and-done.”

The study resulted from CTTI’s investigator community work, which explored factors that influence investigators’ decisions to leave or remain in clinical research practice. Through this research and multi-stakeholder engagement, CTTI created a set of recommendations that systematically address barriers and implement reliable solutions to help reduce attrition of first-time and veteran investigators who leave the research environment.

New CTTI Publication Maps the Road Ahead for Decentralized Clinical Trials

A peer-reviewed article highlighting CTTI recommendations for Decentralized Clinical Trials (DCTs) was published this month in Therapeutic Innovation and Regulatory Science. The article describes the process of identifying and addressing the legal, regulatory, and practical hurdles for planning and conducting DCTs.

DCTs, which are run through telemedicine and mobile health care providers, offer several potential advantages, such as faster recruitment, improved retention, greater control and convenience for participants, and increased participant diversity. CTTI’s evidence-based and practical recommendations address roadblocks that could be hindering the widespread use of DCTs.

The article covers recommendations about trial design and conduct, telemedicine state licensing, medical product supply chain, mobile health care providers, investigator delegation and oversight, and safety monitoring that can help the industry navigate real and perceived barriers in the road to greater adoption.

Study Start-Up

Topics Included: Site Planning

Study start-up (SSU) for randomized controlled trials is usually a long and costly process that can cause significant delays.  

Addressing this challenge, CTTI conducted work to identify specific metrics and benchmarks related to SSU, recommending greater standardization within the clinical trials ecosystem. More recently, it also conducted research and released report showing that budgets and contracts are significant contributors to delays, laying the groundwork for future industry work on remodeling the SSU process. 

Resources

Site Planning | CTTI News

CTTI Article Uncovers Why Principal Investigators Conduct Multiple FDA-Regulated Drug Trials

Building on a previous study on the reasons why principal investigators conduct only one FDA-regulated drug trial (“one-and-done” investigators), a new CTTI article published in Contemporary Clinical Trials Communications explores the converse: barriers and...

Site Planning | CTTI News

New CTTI Publication Maps the Road Ahead for Decentralized Clinical Trials

A peer-reviewed article highlighting CTTI recommendations for Decentralized Clinical Trials (DCTs) was published this month in Therapeutic Innovation and Regulatory Science. The article describes the process of identifying and addressing the legal, regulatory, and...

Site Planning

Study Start-Up

Study start-up (SSU) for randomized controlled trials is usually a long and costly process that can cause significant delays.

Site Planning | Publications

Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative

Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative

Site Planning | CTTI News

New Paper Offers Recommendations for Efficient Identification and Training of Investigators

CTTI has released a new preprint paper describing its recommended approach for identifying and preparing investigators and their delegates to perform clinical research. The paper suggests that by moving beyond Good Clinical...

Site Planning | CTTI News

Webinar Now Available: CTTI’s New Recommendations for Using Real-World Data Sources to Enhance Trial Quality and Efficiency

A recording is now available of the public webinar held on Thurs., Oct. 17, to launch CTTI’s new recommendations for using real-world data (RWD) to plan trial eligibility criteria and recruit participants....

Site Planning | CTTI News

CTTI Investigator Community Recommendations Featured in Contemporary Clinical Trials Communications

Why are turnover rates so high for site investigators? What can be done to strengthen the investigator community? CTTI’s exploration of this question and resulting recommendations were published this week in...

Site Planning | Press Releases

CTTI Releases New Recommendations and Resources for Using Real-World Data to Plan Trial Eligibility Criteria and Recruit Participants

CTTI Releases New Recommendations and Resources for Using Real-World Data to Plan Trial Eligibility Criteria and Recruit Participants

Site Planning | Publications

Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative

Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative

Site Planning | Resources

Appendix 2: Mentoring and Knowledge-Sharing Examples

Appendix 2: Mentoring and Knowledge-Sharing Examples

Formats

Stage of Trial

Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative

Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative

New Paper Offers Recommendations for Efficient Identification and Training of Investigators

CTTI has released a new preprint paper describing its recommended approach for identifying and preparing investigators and their delegates to perform clinical research. The paper suggests that by moving beyond Good Clinical Practice (GCP) training as a one-size-fits-all solution, sponsors, CROs, investigators, and other research professionals may be able to more efficiently find and train investigators for quality research.

Specifically, CTTI recommends complementing previous GCP training with a fit-for-purpose, risk-based training approach to close identified gaps in knowledge or skills. This multifaceted approach to training can enrich understanding of how GCP principles apply to the conduct of a particular clinical trial and help investigators grasp how to better apply quality principles in a specific setting. Combining the real-world application of GCP principles with role- and protocol-specific instruction has the potential to add greater value to the investigator qualification process, leading to the higher quality conduct of trials.

CTTI used findings from qualitative research with investigators and clinical trial sponsors, along with input from an expert meeting with multiple stakeholders, to develop the recommendations. The research identified gaps and redundancies in the current training of investigators and their delegates, as well as a common theme: the didactic, one-size-fits-all approach most commonly used for training investigators and documenting their qualification often introduces redundancies and minimizes the value of previous training.

In the paper, CTTI offers detailed recommendations for how sponsors, CROs, and site teams can respond to these insights and positively shift the investigator training culture, as well as further discussion of how a targeted learning approach can better prepare investigators and their delegates to conduct quality clinical trials.

Webinar Now Available: CTTI’s New Recommendations for Using Real-World Data Sources to Enhance Trial Quality and Efficiency

recording is now available of the public webinar held on Thurs., Oct. 17, to launch CTTI’s new recommendations for using real-world data (RWD) to plan trial eligibility criteria and recruit participants. The webinar was led by Sudha Raman of Duke University, and Jack Sheehan of Janssen Scientific Affairs.

CTTI conducted research and collaborated with stakeholders across the clinical trials ecosystem to develop these recommendations and resources, including three in-depth case studies that elucidate the process of integrating RWD into trial design. The case studies offer a look into the specific challenges faced by each sponsor, how they used RWD to address those challenges, and what they learned along the way.

This project is one in a growing portfolio of CTTI work focused on improving quality in trials and embracing novel trial designs. Other related CTTI efforts include:

  • Co-leading a proof-of-concept study to assess the feasibility of using the FDA Sentinel System infrastructure to conduct randomized clinical trials.
  • Recommendations on how to assess and design registries so that the data can meet expectations for the FDA review of new products.
  • Recommendations and a robust toolkit to help drive a Quality by Design (QbD) approach, which engages a broad range of stakeholders and focuses resources on the errors that matter to decision making.

Both the webinar and CTTI’s latest recommendations and resources can be found on CTTI’s website.

CTTI Investigator Community Recommendations Featured in Contemporary Clinical Trials Communications

Why are turnover rates so high for site investigators? What can be done to strengthen the investigator community? CTTI’s exploration of this question and resulting recommendations were published this week in the peer-reviewed journal Contemporary Clinical Trials Communications.

 

CTTI’s work on improving the Investigator Community aimed to better understand why some clinical investigators remain actively engaged in clinical research but others decide to leave it after a single experience. Evidence suggests that many investigators are leaving clinical research due to burdens imposed by trial-related responsibilities—a trend that could hinder the quality and efficiency of clinical trials.

CTTI’s evidence-based recommendations address the challenges faced by site investigators and offer solutions for improving their experience. The recommendations focus on streamlining research infrastructure and staff, clarifying site budget and contract negotiations, optimizing trial execution and conduct, and providing opportunities to conduct additional trials. CROs, sponsors, health systems, investigators, and others can use CTTI’s work to create a research environment that sustains long-term engagement, and fosters improved quality and efficiency in clinical trials.